Planet 13 Holdings (PLNH) Share-based Compensation (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Share-based Compensation came in at $694263.0 in Q1 2026, up 1050.76% year-on-year from $60331.0 in Q1 2025, and down 40.26% on a QoQ basis from $1.2 million in Q4 2025.
Planet 13 Holdings (PLNH) Share-based Compensation (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Share-based Compensation data on file, last reported at $694263.0 in Q1 2026.
- On a quarterly basis, Share-based Compensation rose 1050.76% year-over-year to $694263.0 in Q1 2026; TTM through Mar 2026 was $3.0 million, a 2079.31% increase from a year earlier, with the FY2025 full-year figure at $2.3 million, up 1195.83% from the prior year.
- Share-based Compensation for Q1 2026 stood at $694263.0, down from $1.2 million in the prior quarter.
- Over the last five years, Share-based Compensation for PLNH reached as high as $2.1 million in Q2 2022 and fell as low as -$980189.0 in Q4 2023.
- Historically, Share-based Compensation has averaged $635356.1 across 5 years, with a median of $616654.0 in 2025.
- Across the five-year window, Share-based Compensation sank 175.11% in 2023 and surged 4472.91% in 2025, its largest moves.
- Year by year, Share-based Compensation stood at $1.3 million in 2022, then sank by 175.11% to -$980189.0 in 2023, then surged by 102.59% to $25415.0 in 2024, then jumped by 4472.91% to $1.2 million in 2025, then tumbled by 40.26% to $694263.0 in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $694263.0 in Q1 2026, $1.2 million in Q4 2025, and $616654.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | 694,263.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 694,263.00 |
| Mar 31, 2026 | 694,263.00 |
| Dec 31, 2025 | 1.16 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 616,654.00 |
| Sep 30, 2025 | 616,654.00 |
| Jun 30, 2025 | 497,296.00 |
| Jun 30, 2025 | 497,296.00 |
| Mar 31, 2025 | 60,331.00 |
| Mar 31, 2025 | 60,331.00 |
| Dec 31, 2024 | 25,415.00 |
| Dec 31, 2024 | 25,415.00 |
| Sep 30, 2024 | 25,416.00 |
| Sep 30, 2024 | 25,416.00 |
| Jun 30, 2024 | 25,139.00 |
| Jun 30, 2024 | 25,139.00 |
| Mar 31, 2024 | 104,338.00 |
| Mar 31, 2024 | 104,338.00 |
| Dec 31, 2023 | -980,189.00 |
| Dec 31, 2023 | -980,189.00 |